Sage Therapeutics, Inc.Sage Therapeutics, Inc.Sage Therapeutics, Inc.

Sage Therapeutics, Inc.

No trades
See on Supercharts

Price target

22.290.00 0.00%
The 17 analysts offering 1 year price forecasts for SAGE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 21 analysts giving stock ratings to SAGE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SAGE EPS for the last quarter is −1.80 USD despite the estimation of −1.65 USD. In the next quarter EPS is expected to reach −1.67 USD. Track more of Sage Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Sage Therapeutics, Inc. revenue is expected to reach ‪8.96 M‬ USD. Check out Sage Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SAGE price target is 22.29 USD with a max estimate of 70.00 USD and a min estimate of 14.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with SAGE news and stock market news.
We've gathered opinions of 21 analysts rating SAGE stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.